Integrin-linked kinase regulates melanoma angiogenesis by activating NF-B/interleukin-6 signaling pathway

Oncogene

Volumn 30, Issue 24, 2011, Pages 2778-2788

  Wani, A A ^a   Jafarnejad, S M ^a   Zhou, J ^b   Li, G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

angiogenesis; IL 6; ILK; melanoma; NF kB; VEGF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN LINKED KINASE; INTERLEUKIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79958789624     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.644     Document Type: Article

References (48)

1. Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel DT, Nishimoto N. (2006). Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int J Cancer 119: 1303-1311. (Pubitemid 44258804)
2. Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA. (2003). Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol 201: 229-237. (Pubitemid 37258934)
3. Bravou V, Klironomos G, Papadaki E, Stefanou D, Varakis J. (2003). Integrin-linked kinase (ILK) expression in human colon cancer. Br J Cancer 89: 2340-2341. (Pubitemid 38168021)
4. Chen LF, Greene WC. (2004). Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401.
5. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. (1996). Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271: 736-741. (Pubitemid 26034921)
6. Czubayko F, Schulte AM, Berchem GJ, Wellstein A. (1996). Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc Natl Acad Sci USA 93: 14753-14758. (Pubitemid 26419041)
7. Dai DL, Makretsov N, Campos EI, Huang C, Zhou Y, Huntsman D et al. (2003). Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin Cancer Res 9: 4409-4414. (Pubitemid 37248398)
8. D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B et al. (2000). The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275: 32649-32657.
9. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. (1998). Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211-11216. (Pubitemid 28450107)
10. Delrieu I, Faye JC, Bayard F, Maret A. (1999). Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cells. Biochem J 340(Part 1): 201-206. (Pubitemid 29251107)
11. Dutcher JP. (2001). Angiogenesis and melanoma. Curr Oncol Rep 3: 353-358.
12. Gao K, Dai DL, Martinka M, Li G. (2006). Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration. Cancer Res 66: 8382-8388. (Pubitemid 44449148)
13. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW et al. (2001). Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 7: 1987-1991. (Pubitemid 32994836)
14. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J et al. (1996). Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379: 91-96. (Pubitemid 26008142)
15. Hershko DD, Robb BW, Luo G, Hasselgren PO. (2002). Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am J Physiol Regul Integr Comp Physiol 283: R1140-R1148. (Pubitemid 35216988)
16. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A et al. (2004). Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 5270-5282. (Pubitemid 39006547)
17. Houghton AN, Polsky D. (2002). Focus on melanoma. Cancer Cell 2: 275-278. (Pubitemid 41043961)
18. Huang SP, Wu MS, Shun CT, Wang HP, Lin MT, Kuo ML et al. (2004). Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J Biomed Sci 11: 517-527.
19. Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H et al. (2003). Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma. Virchows Arch 442: 118-123. (Pubitemid 36337658)
20. Jee SH, Chu CY, Chiu HC, Huang YL, Tsai WL, Liao YH et al. (2004). Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways. J Invest Dermatol 123: 1169-1175.
21. Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ. (2000). Early detection and treatment of skin cancer. Am Fam Physician 62: 357-368, 375-356, 381-352.
22. Karst AM, Gao K, Nelson CC, Li G. (2009). Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. Int J Cancer 124: 494-501.
23. Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ et al. (2005). Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther 4: 1681-1688. (Pubitemid 41685302)
24. Lazar-Molnar E, Hegyesi H, Toth S, Falus A. (2000). Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12: 547-554. (Pubitemid 30453481)
25. Libermann TA, Baltimore D. (1990). Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10: 2327-2334.
26. Loeffler S, Fayard B, Weis J, Weissenberger J. (2005). Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115: 202-213. (Pubitemid 40586728)
27. Lynch DK, Ellis CA, Edwards PA, Hiles ID. (1999). Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18: 8024-8032. (Pubitemid 30050563)
28. Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB et al. (2000). Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 275: 21340-21348. (Pubitemid 30481833)
29. Mahnke JL, Dawood MY, Huang JC. (2000). Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril 73: 166-170. (Pubitemid 30018043)
30. Matsui H, Ihara Y, Fujio Y, Kunisada K, Akira S, Kishimoto T et al. (1999). Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc Res 42: 104-112. (Pubitemid 29167075)
31. Mouawad R, Rixe O, Meric JB, Khayat D, Soubrane C. (2002). Serum interleukin-6 concentrations as predictive factor of time to progression in metastatic malignant melanoma patients treated by biochem-otherapy: a retrospective study. Cytokines Cell Mol Ther 7: 151-156. (Pubitemid 37531603)
32. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J et al. (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008. (Pubitemid 34270888)
33. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J et al. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97: 3207-3212. (Pubitemid 30183280)
34. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D et al. (2001). Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276: 27462-27469.
35. Persad S, Dedhar S. (2003). The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 22: 375-384. (Pubitemid 36791893)
36. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM et al. (2000). The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88: 2398-2424. (Pubitemid 30247142)
37. Saidi A, Hagedorn M, Allain N, Verpelli C, Sala C, Bello L et al. (2009). Combined targeting of interleukin-6 and vascular endothe-lial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer 125: 1054-1064.
38. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. (1999). IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353-30356.
39. Soengas MS, Lowe SW. (2003). Apoptosis and melanoma chemore-sistance. Oncogene 22: 3138-3151.
40. Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K et al. (2004). Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5: 79-90. (Pubitemid 38121598)
41. Tan C, Mui A, Dedhar S. (2002). Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-kappa B-dependent manner. J Biol Chem 277: 3109-3116. (Pubitemid 34953171)
42. Troussard AA, Mawji NM, Ong C, Mui A, St -Arnaud R, Dedhar S. (2003). Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278: 22374-22378. (Pubitemid 36830287)
43. Troussard AA, Tan C, Yoganathan TN, Dedhar S. (1999). Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner. Mol Cell Biol 19: 7420-7427. (Pubitemid 29493405)
44. Watanabe M, Fujioka-Kaneko Y, Kobayashi H, Kiniwa M, Kuwano M, Basaki Y. (2005). Involvement of integrin-linked kinase in capillary/tube-like network formation of human vascular endothe-lial cells. Biol Proced Online 7: 41-47. (Pubitemid 41358166)
45. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN et al. (2003). Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22: 1517-1527.
46. Wong RP, Ng P, Dedhar S, Li G. (2007). The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol Cancer Ther 6: 1692-1700. (Pubitemid 46954045)
47. Wu C, Dedhar S. (2001). Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155: 505-510. (Pubitemid 34289309)
48. Xiao W, Hodge DR, Wang L, Yang X, Zhang X, Farrar WL. (2004). Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer- binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells. Prostate 61: 354-370. (Pubitemid 39564278)